Vacant job
- Jobs
- Director, Project Toxicologist, BioPharma Safety at AstraZeneca
Director, Project Toxicologist, BioPharma Safety at AstraZeneca
Astrazeneca ABVästra Götalands län, Göteborg
12 days left
to apply for the job
At AstraZeneca, it is our bold ambition to achieve disease modification, clinical remission, and cure, to impact the lives of millions of people worldwide suffering from cardiovascular, renal, metabolic and respiratory diseases. We are now expanding our diverse pipeline to secure leadership in numerous BioPharma indications.
We are looking for a motivated and passionate individual to join us as a Director, Project Toxicologist, BioPharma Safety with a focus on enabling the delivery of transformative and safe drugs to patients. This is a Senior Project Toxicology position. As an individual contributor you will provide non-clinical safety expertise for our diverse portfolio containing a broad range of drug modalities. This high-impact development role supports the advancement of the BioPharma pipeline by designing, planning and interpreting toxicology studies, assessing safety risks, and contributing to project strategy supporting all phases of clinical development. The position is based in a collaborative, multidisciplinary environment within the Clinical Pharmacology and Safety Sciences (CPSS) function.
The position will be based at one of our vibrant strategic R&D site in Gothenburg, Sweden.
What you will do
As a Director, Project Toxicologist in BioPharma Safety at AstraZeneca, your main accountabilities will be:
- As a core member of multi-disciplinary BioPharma drug development teams, you will design, deliver, and interpret innovative toxicology strategies to predict, assess and mitigate target- and modality related safety risks.
- Develop and implement innovative solutions to combine regulatory toxicology with groundbreaking science and technologies to progress novel drug candidates to the clinic and through development to the market, in line with business needs.
- To influence project strategy and decision making, you will communicate clear positions on integrated risk assessments in various formats including informing internal decision-making governance bodies and interacting with external health authorities.
- Delivering quality nonclinical summaries and contribute to regulatory submissions.
- Maintain expertise in regulatory requirements and preclinical safety approaches applied to Drug Candidates and awareness of industry trends.
- Additional responsibilities include to provide experienced nonclinical evaluation of in-licensing and out-licensing opportunities and to provide mentorship and guidance to emerging toxicologists with respect to the regulatory environment and support their career growth and development in this field.
Essential requirements for this role
- A PhD in toxicology, cell biology, pharmacology, systems biology, or a related scientific discipline, or an advanced university degree accompanied by at least 10 years of relevant professional experience.
- Extensive experience in the pharmaceutical or biotechnology industry working as a non-clinical safety lead, supporting cardiovascular, renal, metabolic or respiratory programs with planning, execution, interpretation and communication of regulatory toxicology data.
- Experience with design of strategies and execution of in vitro and in vivo experiments to determine the safety and efficacy of cardiovascular, renal, and metabolism therapeutics.
- Demonstrates a proven understanding of end-to-end drug development with a track record delivering toxicology programs from IND through late stage clinical development. Late-stage experience leading or contributing to New Drug Application (NDA) and/or Biologics License Application (BLA) submissions is essential for the role.
- Strong understanding of regulatory guidelines and experience with compilation of toxicology information into regulatory submission documents.
- Exhibits excellent verbal and written communication, strong interpersonal effectiveness, and the ability to influence stakeholders at all levels; this capability is essential for the role.
- Demonstrates an inclusive, collaborative working style that builds trust and shared ownership; combines a hands-on drive to dive into details when needed with a strong commitment to enabling others' success, consistently acting with an enterprise mindset across teams and functions.
- Ability to solve problems in a goal-focused fashion with willingness to challenge conventional thinking and capacity to coordinate tasks across multiple projects.
- Represent AstraZeneca interests, maintaining high ethical and scientific standards.
- Established record of scientific contribution in peer-reviewed journals and scientific symposiums.
- Experience with various modalities, such as small molecules, siRNAs, ASOs, peptides, and biologics for example.
Desirable in the role
- Certifications such as Diplomate of the American Board of Toxicology (DABT) and/or European Registered Toxicologist (ERT) is preferred.
When we put unexpected teams in the same room, we unleash bold thinking with the power to inspire life-changing medicines. In-person working gives us the platform we need to connect, work at pace and challenge perceptions. That's why we work, on average, a minimum of three days per week from the office. But that doesn't mean we're not flexible. We balance the expectation of being in the office while respecting individual flexibility. Join us in our unique and ambitious world.
So, what's next?
Are you already imagining yourself joining us? Good, because we can't wait to hear from you!
Welcome with your application; CV and cover letter, no later than 28 February, 2026.
🖐 Was this job fit for someone?
Other jobs in the same field
Maybe it’s time to broaden the search with these available jobs
-
Specialists in environmental protection and environmental technology
Göteborgs Stads Bostads AB
Fri, 13 Feb 2026 - 06:18
-
Opinion Polls: Kantar-Sifo shows increased support for S, decline for SD and C
Fri, 13 Feb 2026 - 01:35 -
Policy rate remains at 1.75% – Riksbank signals stability
Thu, 29 Jan 2026 - 14:02